Advanced Therapies Week 2027 is a premier event dedicated to advancing therapeutic solutions for future patients. It convenes industry leaders, researchers, and innovators from the advanced therapies sector, including academia, biotech, and pharma industries. The event provides a crucial platform to explore the latest developments and breakthroughs in regenerative medicine, gene therapy, and cell therapy. Professionals focused on cell and gene therapy development and manufacturing will find immense value, with an emphasis on innovation across the entire drug development pipeline, from early research to commercialization. Attendees will benefit from a comprehensive program featuring keynote speakers, insightful panel discussions, thought-provoking plenary sessions, and practical workshops. These sessions delve into critical topics such as manufacturing, commercialization strategies, clinical trials, and navigating regulatory pathways. This week offers an unparalleled opportunity for senior-level industry and public sector figures to connect, learn, and contribute to the future of advanced therapies.
Highlights
4 items
01
Focus on Advanced Therapies
Premier event exploring the latest breakthroughs in regenerative medicine, gene therapy, and cell therapy for future patients.
02
Innovation Across Pipeline
Emphasizes innovation throughout the drug development pipeline, from early research to commercialization strategies.
03
Comprehensive Program
Features keynote speakers, panel discussions, plenary sessions, and workshops on manufacturing, clinical trials, and regulatory pathways.
04
Targeted Networking
Connects industry leaders, researchers, innovators, and senior professionals from academia, biotech, and pharma.
Previous Edition
2,000
Attendees
110
Exhibitors
—
Net Area
FAQ
3 questions
Tickets are available through a pre-sale system, including limited Super Early Bird passes via private links and VIP packages offering premium access and exclusive perks.
The event covers cell and gene therapy R&D, regulatory business models, indications, technologies, process & product development, manufacturing, commercialization, and clinical trials.
It's for industry leaders, researchers, innovators, and senior-level professionals from academia, biotech, and pharma involved in cell & gene therapy and regenerative medicine.
